-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Forum official website: style="vertical-align: inherit;">On October 22-23, 2021, hosted by the Chinese Society of Bioengineering and Shanghai Shangtu Information BIOMAP, and supported by the Precision Medicine Professional Committee of the Chinese Society of Bioengineering and the In Vitro Diagnosis (IVD) Branch of the China Medical Device Industry Association, P4 China 2021 Fifth The International Oncology Precision Medicine Conference will be held at the U-Town Crown Hotel in Chaoyang District, Beijing
More than 50 heavy guests, including academician authority / clinical examination center / supervision of the China National Supervision Institute / tumor clinical / leading diagnostic industry / precision pharmaceutical company experts, attended the meeting, focusing on the precise diagnosis and treatment of tumors, from prevention to diagnosis to treatment, from early screening , Staging and typing, prognostic testing, companion diagnostics, biomarkers, precision immune/targeted drug development and transformation, etc.
Participants:
In vitro diagnostics regulatory agencies (Health Commission / National Food and Drug Administration / China National Inspection Institute, etc.
Technical innovation and application of early tumor screening/assisted early diagnosis/typing/prognosis at venue A
DAY1 ( 10 Yue 22 days) | DAY2 ( 10 Yue 23 days) |
Interpretation of the latest compliance policies and clinical recommendations for application and registration | Follow up with the latest application of single cell /RNA sequencing screening technology |
Follow up the development prospects and market opportunities of tumor screening and diagnosis | Analyze MRD/MSI and other testing and product development evaluation |
Learning and innovation, early screening of markers / methods, forward-looking research and other frontier developments | Explore the detection of tumor types / prognosis and other markers and technological innovation |
Listen to the innovative technology of liquid biopsy for early tumor screening / assisted diagnosis | Learn multi-omics / immunomics / new detection techniques such as mass spectrometry |
Listen to the innovative technology of liquid biopsy for early tumor screening / assisted diagnosis | Learn multi-omics / immunomics / new detection techniques such as mass spectrometry |
[A first look at some of the exciting topics in Venue A]
• Under the latest medical device supervision regulations: Interpretation of LDT compliance
.
Venue A has confirmed guests (the guest lineup is being updated continuously)
Li Jinming, Researcher
DAY1 ( 10 Yue 22 days) | DAY2 ( 10 Yue 23 days) |
Explore the development of immune / targeted drugs under the guidance of biomarkers | Study companion diagnostic testing standards / product development and drug transformation |
Learn the latest immunotherapy / immune combination and research progress of markers | Unlock the precise clinical and transformation of drugs in the companion diagnostic mode |
Analyze pathway / target research to accelerate targeted drug conversion | Analyze the development of biomarkers and cell therapy / combination and double antibody development |
Explore the precise clinical development and transformation of drugs under the guidance of biomarkers | Digging deep into genetic testing and hyper-personalized immunotherapy drug development |
Special Session of the Precision Medicine Committee of the Chinese Society of Bioengineering
Yao Shukun, Former Vice President of China-Japan Friendship Hospital, Chairman of the Precision Medicine Committee of the
[First look at some exciting topics in venue B]
• New progress in the research of new tumor immunotherapy drugs
.
More confirmed guests at venue B (the guest lineup is being continuously updated)
Now four people sign up and enjoy a 25% discount on group purchase.
[More] welfare concessions
For details, please check the official website link: https:// style="vertical-align: inherit;">Participating in P4 China 2021 & IGC 2021 at the same time from now on
For details, please check the official website link: https:// style="vertical-align: inherit;">For more forum information, please contact the P4 Organizing Committee: